55. 再発性多発軟骨炎 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 10 / 薬物数 : 14 - (DrugBank : 12) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 111

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Abatacept
   Benaroya Research Institute
      2011   Phase 1   NCT01272856   United States
Adalimumab
   University of Pennsylvania
      2025   Phase 2   NCT06941376   United States
Azathioprine
   University of Pennsylvania
      2025   Phase 2   NCT06941376   United States
Ciclosporin
   St. Marianna University School of Medicine
      2010   -   JPRN-UMIN000003869   Japan
Corticosteroids and immunosuppressants
   Peking University People's Hospital
      2024   Phase 1/Phase 2   NCT06873100   China
Dimension
   St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
      2011   -   JPRN-UMIN000006950   Japan
Infliximab
   Cambridge University Hospitals NHS Foundation Trust
      2021   Phase 2   NCT05168475   United Kingdom
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom
   University of Pennsylvania
      2025   Phase 2   NCT06941376   United States
Interleukin-2
   Peking University People's Hospital
      2019   Phase 2   NCT04077736   China
Methotrexate
   St. Marianna University School of Medicine
      2010   -   JPRN-UMIN000003869   Japan
   University of Pennsylvania
      2025   Phase 2   NCT06941376   United States
MTX
   University of Pennsylvania
      2025   Phase 2   NCT06941376   United States
Rituximab
   Cambridge University Hospitals NHS Foundation Trust
      2021   Phase 2   NCT05168475   United Kingdom
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom
Tiotropium
   St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
      2011   -   JPRN-UMIN000006950   Japan
Tocilizumab
   Cambridge University Hospitals NHS Foundation Trust
      2021   Phase 2   NCT05168475   United Kingdom
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom
   Children's Hospital of Eastern Ontario
      2010   -   NCT01041248   Canada
   McMaster Children's Hospital
      2010   Phase 2   NCT01104480   Canada
   University of Pennsylvania
      2025   Phase 2   NCT06941376   United States
Upadacitinib
   Peking University People's Hospital
      2024   Phase 1/Phase 2   NCT06873100   China